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INTRODUCTION:  Post-hepatectomy  liver  failure  (PHLF)  is  one  of the  most  serious  complications  of liver
resection  and  is  associated  with  high  morbidity  and  mortality  rates.
PRESENTATION  OF  CASE:  We  report  a case  of  PHLF  involving  clinical  presentation  of  posthepatectomy-
related  ‘small-for-size’  syndrome  (SFSS)  secondary  to obstructed  venous  outﬂow  in  the  liver  remnant,
following  extended  right  hepatectomy.eywords:
ost-hepatectomy liver failure
mall-for-size syndrome
epatobiliary surgery
nterventional radiology
DISCUSSION:  PHLF  is  similar  to SFSS  in liver  transplantation  (LT) in terms  of  pathogenesis,  clinical  pre-
sentation  and  outcomes.  Although  inﬂow  hypertension  is clearly  implicated  in  the pathogenesis  of  SFSS
some authors  have  suggested  that  outﬂow  obstruction  is a potential  pathogenic  factor.
CONCLUSION:  The  present  case  support  the  hypothesis  that  outﬂow  obstruction  could  lead  symptoms
similar  to  SFSS.
©  2015  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Post-hepatectomy liver failure (PHLF) is one of the most seri-
us complications of liver resection and is associated with high
orbidity and mortality [1,2]. It is important to determine the risk
actors for PHLF in order to identify the patients most at risk, and
o facilitate implementation of strategies to reduce the incidence
nd associated mortality [1]. One of the main surgical risk factors
s extent of resection, since extended hepatic resection can result
n a small remnant liver volume (SRLV) [1]. This condition may  be
inked to the ‘small-for-size’ syndrome (SFSS) known in liver trans-
lantation (LT) as the two conditions have similar pathogenesis,
linical presentation and outcomes. Although inﬂow hypertension
s known to be implicated in SFSS pathogenesis it has also been sug-
ested that outﬂow obstruction is a potential pathogenic factor [3].
ecent pre-clinical experimental research in rats provided support
or the hypothesis [3–5].
In support of the hypothesis that outﬂow obstruction could lead
o symptoms similar to SFSS, we report a case of PHLF involving
linical presentation of posthepatectomy-related SFSS secondary to
bstructed venous outﬂow in the liver remnant following extended
ight hepatectomy.∗ Corresponding author.
E-mail address: martin.lhuaire@etudiant.univ-reims.fr (M.  Lhuaire).
ttp://dx.doi.org/10.1016/j.ijscr.2015.10.001
210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Assoc
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2. Case report
In July 2014 a 64-year-old male with a history of hyperten-
sion and tobacco consumption, moderate obesity (BMI = 31 kg/m2,
weight = 91 kg, height = 1.71 m)  and moderate alcohol consumption
(30 g/day) was  referred to our center for the management of a his-
tologically conﬁrmed 9 cm hepatocellular carcinoma of the right
liver. His liver had moderate steatosis without ﬁbrosis and the
carcinoma was  discovered incidentally on contrast-enhanced CT
during exploration of an appendicular syndrome presenting as an
abdominal pain in the right iliac fossa. Preoperative clinical eval-
uation revealed no liver cirrhosis, no signs of portal hypertension
and normal liver function (prothrombin time, PT = 100%, bilirubine-
mia  = 9 mol/L, albuminemia = 43 g/L, creatininemia = 69 mol/L,
platelet count = 303 G/L). Preoperative histological evaluation of
the non-tumoral parenchyma was  not available. Morphological
investigation using CT and MRI  revealed a 9 cm tumor develop-
ing in the right liver which extended into segment I and segment
IV and was in close contact with the inferior vena cava. The
preoperative liver volumetry results were: total liver, 1924 cm3
(tumor-free volume: 204 cm3); left liver, 484 cm3 (25% of the total
liver volume; future liver remnant-to-body weight ratio: 0.5%); and
right liver, 1644 cm3 (75% of the total liver volume). Surgery con-
sisted of an extended right hepatectomy including segment I using
the Dissectron device (Integra LifeSciences Corp., Plainsboro, NJ,
USA). The remaining left liver was ﬁxed in an anatomical fashion,
under perioperative Doppler ultrasound (DUS) control for vascu-
lar patency, stitched between the remnant falciform ligament and
iates Ltd. This is an open access article under the CC BY-NC-ND license (http://
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and implementation of strategies to reduce the incidence of PHLFig. 1. Coronal cross-section reconstruction of contrast-enhanced hepatic MRI  at ta
 months after surgery.
he diaphragm. During the perioperative period there was  inter-
ittent portal clamping (43 min  in total) associated with 20-min
eriods of caval clamping; the total operating time was  10 h, and
here was no hemodynamic insufﬁciency requiring treatment with
mine drugs. A total of 6 L crystalloids and 2 red blood cells trans-
usions were administrated. Pathological examination conﬁrmed
0 resection of a well-differentiated, encapsulated hepatocellular
arcinoma (Edmondson and Steiner grade II) 9 cm at its maxi-
um  diameter, classiﬁed as pT2 according to the AJCC 2010. There
as evidence of microvesicular or macrovesicular steatosis in 50%
f the non-tumoral parenchyma. The post-operative course was
otable for a non-severe pulmonary embolism on post-operative
ay (POD) 2. On POD 2 the remnant liver volume was  measured
t 711 cm3 (33% of the initial total liver volume; liver-to-body
eight ratio: 0.8%). PHLF occurred on POD 5, deﬁned by PT = 49%,
yperbilirubinemia of 125 mol/L and signiﬁcant ascites (2 L/24 h)
omplicated by sepsis from ascites infection by Proteus mirabilis
hich necessitated antibiotic treatment and transfer to intensive
are. The patient remained in the ICU for 14 days.
On POD 9, the remnant liver volume was measured at 916 cm3
43% of the initial total liver volume; liver-to-body weight ratio:
%). On POD 18 a contrasted-enhanced CT investigation of the PHLF
bilirubin = 565 mol/L, PT = 73%) revealed left hepatic vein steno-
is which was conﬁrmed by DUS, which showed a loss of triphasic
ow. After conﬁrmation of the diagnosis of stricture of the remnant
eft hepatic vein using cavography and assessment of the pressure
radient between the left hepatic vein and inferior veina cava (LHV-
VC gradient = 9 mmHg) a percutaneous transluminal angioplasty
PTA) involving placement of a metallic stent (diameter = 10 mm,
ength = 6 cm;  Misago, Terumo Corp., Tokyo, Japan) within the rem-
ant left hepatic vein was performed to restore normal outﬂow.
fter the procedure the LHV-IVC gradient decreased to 3 mmHg.
he course of post-intervention recovery was uneventful and char-
cterized by a progressive reduction in bilirubinemia. The patienttime showing the metallic stent (white arrow) within the remnant left hepatic vein
was discharged on POD 30. Two  months after surgery the bilirubin
level was  230 mol/L with a normal PT; bilirubinemia was normal
after 4 months. At 10-months follow-up there was no evidence of
late surgical complication; the liver function tests were within nor-
mal  limits and the patient did not complain. Morphological imaging
revealed adequate regeneration of the left remnant liver (1300 cm3,
post-hepatectomy liver remnant-to-body weight ratio 1.2%), with
satisfactory inﬂow and outﬂow and no signs of recurrence of liver
failure. The metallic stent within the left hepatic vein was perme-
able and in place (Fig. 1).
3. Discussion
There is no consensus deﬁnition of PHLF, however most recent
reports have noted an incidence of around 5–10% [1]. The most
widely used criteria for PHLF are the 50–50 criteria [6], peak biliru-
bin >7 mg/dL [7] and the ISGLS criteria [1,2]. In practice clinical
presentation of PHLF typically includes deterioration of one or
more of the synthetic, excretory or detoxifying functions of the
liver and manifests as hyperbilirubinemia, hypoalbuminemia, pro-
longed PT or international normalized ratio (INR), elevated serum
lactate level and hepatic encephalopathy during the post-operative
period [1,2]. Over the past two decades, there has been a decrease
in the incidence of PHLF, presumably as a result of improvements in
surgical technique and perioperative care, which have also reduced
mortality following hepatic resection. Over the past two decades
the mortality rate following partial hepatectomy has remained
at 0–6%, with PHLF contributing to mortality in the majority of
cases [1]. Identifying risk factors for PHLF would help to identify
those patients most at risks and would also facilitate developmentand the associated mortality [1]. To date several independent pre-
dictors of PHLF have been identiﬁed; they can be classiﬁed into
three main categories: patient-related, liver-related, and surgical or
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ost-operative related factors [1]. Extent of resection is one of the
ain surgical risk factors as extended hepatic resection can result
n SRLV [1]; however, Yigilter et al. reported that incidence of PHLF
as not closely correlated with remnant liver volume [8], reﬂecting
he complexity of the mechanisms leading to PHLF. Nevertheless,
HLF is similar to the SFSS recognized in LT in terms of pathogene-
is, clinical presentation and outcomes. The initial description of
FSS were based on experience of living-donor liver transplan-
ation (LDLT) and it was deﬁned as a graft-to-recipient weight
atio (GRWR) of less than 0.8–1% or less than 30–50% of stan-
ard/estimated liver volumes [1,5,9]. The mechanisms underlying
FSS involve increased portal blood ﬂow and portal hypertension,
hich lead to histological injuries in the form of sinusoidal con-
estion and disruption of the sinusoidal lining and hence liver graft
nsufﬁciency and, if the condition remains untreated, liver graft fail-
re [5]. It has been suggested that outﬂow obstruction contributes
o the genesis of SFSS [3] and recent pre-clinical experimental
esearch corroborate this hypothesis [4]. In a rat model involv-
ng ligation of the median hepatic vein combined with 50% partial
epatectomy the authors demonstrated that focal obstruction of
enous outﬂow obstruction in the remnant liver causes conﬂuent
entrilobular necrosis and may  be critically involved in develop-
ent of SFSS [4]. In the case presented here the PHLF symptoms
et  the 50–50 criteria and were associated with a postoperative
iver volume of <1% of body weight (or <50% of initial total liver
olume) and abundant postoperative ascites, leading us to advo-
ate a diagnosis of SRLV or posthepatectomy-related SFSS. DUS
llowed us to rule out portal hypertension and conﬁrm the out-
ow hepatic vein obstruction, but diagnosis was delayed (until
OD 18) because of the unusual PHLF presentation. In conclusion,
his report provides further evidence that outﬂow obstruction is
mplicated in the pathogenesis of PHLF and/or posthepatectomy-
elated SFSS. We  therefore advocate the systematic investigation
f hepatic vein outﬂow when PHLF occurs after extended liver
epatectomy.
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